(Q43646148)
Statements
1 reference
The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance (English)
1 reference
Chitolie A
1 reference
Lawrie AS
1 reference
Mackie IJ
1 reference
Harrison P
1 reference
Machin SJ
1 reference
1 April 2001
1 reference
1 reference
12
1 reference
3
1 reference
179-186
1 reference
Identifiers
1 reference
1 reference